Panama, a Stage for Advances Transforming Critical Care Medicine
International specialists shared in Panama clinical advances and experiences in therapies that are transforming the management of critically ill patients.
Panama City, April 2026 — Panama is consolidating its position as a hub for high-level medical updates with the Panama International Critical Care Congress 2026, a space where innovation, knowledge, and technology come together to strengthen clinical practice in the region.
During the event, international specialists shared advances and experiences in therapies that are transforming the approach to critically ill patients, highlighting innovative elements such as hemoadsorption, which is becoming increasingly relevant in modern intensive care medicine.
In this context, Droguería Ramón González Revilla was present in the congress exhibition area, where it showcased cutting-edge medical technologies and facilitated direct exchange between healthcare professionals and international specialists.
As part of this event, we featured the participation of experts such as Dr. María Taborda from Germany, Dr. Ricard Ferrer from Spain, and Dr. Euclides Cruz from Colombia, who shared updated evidence and clinical cases on the implementation of Cytosorb therapies in different hospital settings.
In addition to the academic component, the booth provided attendees with access to innovative solutions from its portfolio, including technologies from brands such as Cytosorbents, Neuroptics, and Edwards Lifesciences/Becton Dickinson, creating a space for practical interaction and updates on their application within the local clinical environment.
This type of initiative reinforces Droguería Ramón González Revilla’s commitment to the development of the healthcare sector in Panama, promoting access to specialized knowledge and technologies that help raise standards of care in the ICU.
We congratulate the organizing committee for promoting, beyond scientific exchange, participation in these types of spaces that strengthen the connection between global advances and their local implementation, fostering more precise, timely medicine aligned with current patient needs.
